VGI outlines turnaround strategy
Fund manager VGI Partners has detailed its strategy after a tumultuous period of poor returns.
Matt Bell
Latest
ResMed revenue misses top forecasts
ResMed has recorded a 12 per cent rise in quarterly revenue but failed to deliver on expectations a rival’s product recall would result in higher sales.
Gina Rinehart to sponsor Olympic team
A new partnership covering multiple Winter and Summer Games follows mining magnate Gina Rinehart’s sponsorship of Swimming Australia.
ASX roars back; Newcrest sinks 6.4%
Local shares rose 2.2% to close out a volatile week, bond yields cooled slightly and the Aussie dollar hit a seven-week low.
ASX tanks as investors bail
ASX has entered a technical ‘correction’ as investors dump stocks including CSL, CBA and Woodside. Evolution Mining and Silver Lake Resources were also battered, dropping more than 10 per cent.
ASX bloodbath, $59bn wipeout
The ASX suffered a $59bn wipeout amid inflation and geopolitical jitters, ahead of key two-day meeting of the US Federal Reserve. Big four banks dropped between 2 and 3.6 per cent.
Adairs dives as sales plummet
More than $175m has been wiped from the market value of Adairs after the retailer warned higher wage, warehousing and rent costs would hit margins.
ASX falls, led by tech; Uniti roars on takeover talk
ASX closes down by 0.5 per cent on broad falls led by tech and materials. Regis Resources tumbles after guidance cut, Uniti soars on takeover chatter and Fortescue makes $310m battery play.
Former Spaceship CEO banned for faking qualification
An ASIC investigation found Paul Bennetts misused Spaceship Capital’s resources for his personal gain.
ASX dives 2.3% in worst week in 15 months
ASX closes lower with just 12 stocks posting gains. Nuix dives 22.8 per cent on weak outlook, Qantas slashes flights to WA and Fortescue signs MoU for Sinosteel Oakajee stake.
Original URL: https://www.theaustralian.com.au/author/matt-bell/page/105